B. S. Yap - Concepedia

Author

B. S. Yap

Also Known As

B S Yap, B. S. Yap, B. Yap, Beijun Yap, Boh-Seng Yap, K B McCredie

Publications

320

Citations

H-Index

Concepts

All Affiliations

B. S. Yap is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	234
2	Pharmacology	4	4	184
3	Pathology	3	3	163
4	Health Sciences	2	2	135
5	Surgical Oncology	1	1	17

B. S. Yap

Publications

234

Citations

H-Index

Page 1

	Year	Citations
Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. B. S. Yap, Laurence H. Baker, J. G. Sinkovics, PubMed Cancer PharmacologyPathologyMetronomic ChemotherapyCancer ChemotherapyNeuro-oncology	1980	125
The role of schedule in antibiotic therapy of the neutropenic patient Gerald P. Bodey, Manuel Valdivieso, B. S. Yap Infection AntibioticsAntimicrobial StewardshipAntibiotic AdjuvantNeutropenic PatientAntimicrobial Therapy	1980	33
High-dose methotrexate for advanced breast cancer. H. Y. Yap, George R. Blumenschein, B. S. Yap, PubMed Translational MedicineBreast OncologyOncologyMedicineToxic Effects	1979	28
Refractory acute leukaemia in adults treated with sequential colaspase and high-dose methotrexate B. S. Yap, K. B. McCredie, R. S. Benjamin, BMJ Hematological MalignancyRefractory Acute LeukaemiaOncologyMixed-phenotype Acute LeukemiaMalignant Blood Disorder	1978	21
Survival and relapse patterns of complete responders in adults with advanced soft tissue sarcomas (ASTS) B. S. Yap, J. G. Sinkovics, Robert S. Benjamin, Proceedings of the American Association for Cancer Research Complete RespondersSurgical OncologyOncologyRelapse PatternsCancer Recurrence	1979	17
Phase I--II study of 3-deazauridine in adults with acute leukemia. B. S. Yap, K. B. McCredie, Michael J. Keating, PubMed Uridine AnalogMixed-phenotype Acute LeukemiaPharmacotherapyAcute LeukemiaPharmacodynamic Modeling	1981	10

Page 1